...
首页> 外文期刊>European journal of dermatology: EJD >Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.
【24h】

Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.

机译:microRNA加工酶Dicer在皮肤恶性黑色素瘤,良性黑素细胞痣和发育不良的黑素细胞痣中的免疫组织化学表达模式。

获取原文
获取原文并翻译 | 示例
           

摘要

Dicer is an essential cytosolic enzyme necessary for processing pre-microRNAs into mature microRNAs (miRNAs). Although a variety of malignancies have been attributed to perturbations in the miRNA machinery, there has been little research conducted on the role of miRNAs in cutaneous malignant melanoma and its premalignant lesions. In this small pilot study, we therefore investigated the distribution of Dicer by immunohistochemistry in cutaneous malignant melanomas, as well as in benign and dysplastic melanocytic nevi. Dicer was assessed in ten cutaneous malignant melanomas (CMM), benign melanocytic nevi (BMN), and dysplastic melanocytic nevi (DMN), by standard immunohistochemical staining. Semiquantitative analyses determined expression indices (EIs), which associate the conventional area fraction of labeled cells with immunostaining intensity scores, based on visual qualitative examination by two independent observers. Mean EI scores were significantly higher in the CMM group compared to those in the BMN group (p < 0.05). However, EI differences between BMN and DMN as well as between CMM and DMN were not significant (p > 0.05). For CMM we observed a significant correlation of Breslow tumor thickness and Dicer EI (r = 0.84, p = 0.022). For all three groups investigated, Dicer-positive staining was primarily located in the epidermis, specifically in melanocytes. By immunohistochemistry, Dicer staining was significantly higher in melanoma cells than in benign melanocytes. This preliminary study indicates that alterations in the miRNA machinery could exist and should be subject of further investigation.
机译:切酶是将前microRNA加工成成熟microRNA(miRNA)所必需的必需胞质酶。尽管已将多种恶性肿瘤归因于miRNA机制的扰动,但关于miRNA在皮肤恶性黑色素瘤及其恶变前病变中的作用的研究很少。因此,在这项小型先导研究中,我们通过免疫组织化学研究了Dicer在皮肤恶性黑色素瘤以及良性和增生性黑素细胞痣中的分布。通过标准免疫组织化学染色,对十个皮肤恶性黑色素瘤(CMM),良性黑素细胞痣(BMN)和发育异常的黑素细胞痣(DMN)中的Dicer进行了评估。半定量分析基于两个独立观察者的视觉定性检查,确定了表达指数(EI),该指数将标记细胞的常规面积分数与免疫染色强度评分相关联。与BMN组相比,CMM组的EI平均得分显着更高(p <0.05)。但是,BMN和DMN之间以及CMM和DMN之间的EI差异不显着(p> 0.05)。对于CMM,我们观察到了Breslow肿瘤厚度和Dicer EI的显着相关性(r = 0.84,p = 0.022)。对于所研究的所有三个组,Dicer阳性染色主要位于表皮,特别是黑素细胞。通过免疫组织化学,Dicer染色在黑色素瘤细胞中明显高于在良性黑色素细胞中。这项初步研究表明,miRNA机制的改变可能存在,应进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号